Subscribe to RSS - Mick Farrell

Mick Farrell

ResMed believes it has passed nadir in new patient flow

 - 
08/07/2020

SAN DIEGO – ResMed has seen double-digit declines in new sleep apnea patient flow across all markets that have experienced lockdowns due to the COVID-19 pandemic, but the company expects a U-shaped recovery in its fiscal year 2021, says CEO Mick Farrell.

ResMed ‘resilient’ with double-digit growth

 - 
08/06/2020

SAN DIEGO – ResMed reported revenues of $770.3 million for its fourth quarter 2020 ended June 30, an increase of 9% compared to the same quarter one year ago.

ResMed says ‘innovation’ in masks pays off

Company also discusses software investments, competitive bidding
 - 
01/31/2020

SAN DIEGO – ResMed’s masks and accessories hit constant currency growth of 19% in the U.S., Canada and Latin America for the second quarter of fiscal year 2020.

They hit growth of 16% globally.

ResMed reports double-digit growth, announces software acquisition

 - 
01/31/2020

SAN DIEGO – ResMed reported net revenues of $736.2 million for the second quarter ended Dec. 31, 2019, compared to $651.1 million for the same period in 2018, a 13% increase.

ResMed CEO to ring Opening Bell

 - 
09/27/2019

SAN DIEGO – ResMed CEO Mick Farrell will ring the Opening Bell at the New York Stock Exchange on Sept. 30 to celebrate 20 years of being listed on the NYSE and to commemorate ResMed’s 30th anniversary.

ResMed rides connected health wave overseas

 - 
04/27/2018

SAN DIEGO – ResMed got a nice boost from Europe and Asia in the third quarter of fiscal year 2018, as growth in the U.S. slowed slightly.

ResMed highlights ‘positive’ tax changes

 - 
02/27/2018

SAN DIEGO – Tax reform recently passed by Congress has “liberated our global cash assets to be able to be invested without artificial constraints,” ResMed CEO Mick Farrell said during a Jan. 22 conference call.

ResMed sets high expectations for mask sales

Company says it’s ready to ‘unleash’ sales force
 - 
08/04/2017

SAN DIEGO – ResMed expects to see a nice bump in mask sales in the first quarter of its fiscal year 2018, now that it has manufacturing “sufficiently ramped up” for two new masks, the N20 and F20, says CEO Mick Farrell.

ResMed highlights Brightree’s contribution, mask growth in Q3

 - 
04/28/2017

SAN DIEGO – It was Brightree that pushed ResMed into double-digit increases for revenues in the third quarter of fiscal year 2017.

Integration begins for ResMed

Company acquired Inova, Brightree in less than three-month span
 - 
04/29/2016

SAN DIEGO – It’s still early days for recent acquisitions to impact ResMed’s financial results, but Inova Technologies helped to boost the company’s revenues by 2% in the third quarter of fiscal year 2016.

Pages